Sean Maduck - May 2, 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
President, Corcept Endocrinology
Signature
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Sean Nicholas Maduck
Stock symbol
CORT
Transactions as of
May 2, 2022
Transactions value $
$0
Form type
4
Date filed
5/4/2022, 04:12 PM
Previous filing
Feb 15, 2023
Next filing
Jul 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (Right to Buy) Award $0 +50K $0.00 50K May 2, 2022 Common Stock 50K $22.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of April 6, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on April 6, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

President, Corcept Endocrinology